Better Buy: Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals [The Motley Fool]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: The Motley Fool
Two big biotechs. One clear winner. Ascending and descending? That might be how some investors view Vertex Pharmaceuticals ( NASDAQ:VRTX ) and Regeneron Pharmaceuticals ( NASDAQ:REGN ) , respectively. Vertex made less than half the revenue that Regeneron did over the last 12 months, but its market cap is higher than Regeneron's is. It's not surprising that Vertex stock has climbed more than 20% so far in 2018, while Regeneron's share price is in negative territory year to date. Investors are clearly excited about Vertex's new cystic fibrosis drugs. They don't appear nearly as enthused about Regeneron's current products and pipeline, though. But is the conventional wisdom right that Vertex is the better pick? Or could Regeneron be a sleeping giant about to awaken? Image source: Getty Images. The case for Vertex For all practical purposes, Vertex enjoys a monopoly in treating cystic fibrosis (CF). The company's three products -- Kalydeco, Orkambi, and
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- OrthoXel's Vertex Hip Fracture Nail system obtains US clearance [Yahoo! Finance]Yahoo! Finance
- Alpine Immune Sciences Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates [Yahoo! Finance]Yahoo! Finance
- OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN) [Yahoo! Finance]Yahoo! Finance
- Vertex (VRTX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 5/6/24 - Beat
VRTX
Sec Filings
- 5/7/24 - Form 10-Q
- 5/6/24 - Form 8-K
- 5/3/24 - Form 4
- VRTX's page on the SEC website